2015
Nanotechnology Law & Business
By John E. Nappi
In the face of escalating global industrial espionage, companies must vigilantly protect their intellectual property. Indeed, before disclosing to third parties any information that provides a competitive advantage, let alone trade secrets, companies should ensure that each recipient agrees in writing not to disclose or otherwise misuse such information and to be subject to the jurisdiction of U.S. courts—you never know for whom those recipients may work tomorrow. To some, that may seem obvious and to others, overkill. But the downside of not doing so is presently playing out in Ultratech, Inc. v. Ensure Nanotech (Beijing), Inc. et al. in the U.S. District Court for the Northern District of California, in which plaintiff Ultratech is battling to establish personal jurisdiction over defendant Dongjun Wang, a Chinese citizen residing in China who owns the defendant companies and who is accused of patent and copyright infringement, trade secret misappropriation, unfair competition, and breach of contract. In this article, John E. Nappi discusses the posture of the case as of June 2015, as well as defendant Dongjun Wang’s pending motion to dismiss Ultratech’s claims as to him for lack of personal jurisdiction and for failure to state a claim. The authors also discuss some key take-home lessons and reminders concerning the disclosure of confidential business information to third parties, whether foreign or domestic.
Originally printed in Nanotechnology Law & Business, Volume 12, Issue 2 in 2015. This article is for informational purposes, is not intended to constitute legal advice, and may be considered advertising under applicable state laws. This article is only the opinion of the authors and is not attributable to Finnegan, Henderson, Farabow, Garrett & Dunner, LLP, or the firm’s clients.
June 10-12, 2024
San Francisco
Lecture
Patent Protection for Software-Related Inventions in Europe and the USA Training Course
June 5, 2024
Hybrid
10th Annual Georgia Asian Pacific American Bar Association Gala
May 29, 2024
Atlanta
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.